Evidence map›Paper›PMID 36255453›Full record

ArticlePediatric radiology2023

Ventricular function and tissue characterization by cardiac magnetic resonance imaging following hospitalization for multisystem inflammatory syndrome in children: a prospective study.

Michael P DiLorenzo, Kanwal M Farooqi, Amee M Shah, Alexandra Channing, Jamie K Harrington, Thomas J Connors, Karen Martirosyan, Usha S Krishnan, Anne Ferris, Rachel J Weller and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Pediatric radiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Michael P DiLorenzoDepartment of Pediatrics, Division of Cardiology, Columbia University Vagelos College of Physicians and Surgeons and New York - Presbyterian Morgan Stanley Children's Hospital, 3959 Broadway, CHN2, New York, NY, 10032, USA. Mpd2001@cumc.columbia.edu.ORCID 0000-0002-2230-684X
Kanwal M FarooqiDepartment of Pediatrics, Division of Cardiology, Columbia University Vagelos College of Physicians and Surgeons and New York - Presbyterian Morgan Stanley Children's Hospital, 3959 Broadway, CHN2, New York, NY, 10032, USA.
Amee M ShahDepartment of Pediatrics, Division of Cardiology, Columbia University Vagelos College of Physicians and Surgeons and New York - Presbyterian Morgan Stanley Children's Hospital, 3959 Broadway, CHN2, New York, NY, 10032, USA.
Alexandra ChanningDepartment of Pediatrics, Division of Cardiology, Columbia University Vagelos College of Physicians and Surgeons and New York - Presbyterian Morgan Stanley Children's Hospital, 3959 Broadway, CHN2, New York, NY, 10032, USA.
Jamie K HarringtonDepartment of Pediatrics, Division of Cardiology, Columbia University Vagelos College of Physicians and Surgeons and New York - Presbyterian Morgan Stanley Children's Hospital, 3959 Broadway, CHN2, New York, NY, 10032, USA.
Thomas J ConnorsDepartment of Pediatrics, Division of Critical Care, Columbia University Vagelos College of Physicians and Surgeons and New York - Presbyterian Morgan Stanley Children's Hospital, New York, NY, USA.
Karen MartirosyanDepartment of Pediatrics, Division of Cardiology, Columbia University Vagelos College of Physicians and Surgeons and New York - Presbyterian Morgan Stanley Children's Hospital, 3959 Broadway, CHN2, New York, NY, 10032, USA.
Usha S KrishnanDepartment of Pediatrics, Division of Cardiology, Columbia University Vagelos College of Physicians and Surgeons and New York - Presbyterian Morgan Stanley Children's Hospital, 3959 Broadway, CHN2, New York, NY, 10032, USA.
Anne FerrisDepartment of Pediatrics, Division of Cardiology, Columbia University Vagelos College of Physicians and Surgeons and New York - Presbyterian Morgan Stanley Children's Hospital, 3959 Broadway, CHN2, New York, NY, 10032, USA.
Rachel J WellerDepartment of Pediatrics, Division of Cardiology, Columbia University Vagelos College of Physicians and Surgeons and New York - Presbyterian Morgan Stanley Children's Hospital, 3959 Broadway, CHN2, New York, NY, 10032, USA.
Donna L FarberDepartment of Microbiology and Immunology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.
Joshua D MilnerDepartment of Pediatrics, Division of Pediatric Allergy, Immunology, and Rheumatology, Columbia University Vagelos College of Physicians and Surgeons and New York - Presbyterian Morgan Stanley Children's Hospital, New York, NY, USA.
Mark GorelikDepartment of Pediatrics, Division of Pediatric Allergy, Immunology, and Rheumatology, Columbia University Vagelos College of Physicians and Surgeons and New York - Presbyterian Morgan Stanley Children's Hospital, New York, NY, USA.
Erika B RosenzweigDepartment of Pediatrics, Division of Cardiology, Columbia University Vagelos College of Physicians and Surgeons and New York - Presbyterian Morgan Stanley Children's Hospital, 3959 Broadway, CHN2, New York, NY, 10032, USA.
Brett R AndersonDepartment of Pediatrics, Division of Cardiology, Columbia University Vagelos College of Physicians and Surgeons and New York - Presbyterian Morgan Stanley Children's Hospital, 3959 Broadway, CHN2, New York, NY, 10032, USA.
Columbia University Interdisciplinary Multisystem Inflammatory Syndrome in Children Follow-up Program and the Columbia University Irving Medical Center Pediatric/Adult Congenital Heart Research Collaborative
Morgan Stanley Children's Hospital · USColumbia University · US

Funding

Development of lung T cell responses in infant respiratory immunityU01AI100119 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI FARBER, DONNA L. · 2017 to 2021
$3.9M
Development of Localized T Cell Immunity in Pediatric Respiratory Tract InfectionK23AI141686 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CONNORS, THOMAS · 2019 to 2023
$973k
The Congenital Heart Technical Skill Study: Improving Outcomes for Infants and Children with Congenital Heart DiseaseK23HL133454 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ANDERSON, BRETT ROMEO · 2017 to 2019
$572k
Genentech ML42866NHLBI NIH HHS K23AI141686NHLBI NIH HHS K23 HL133454NHLBI NIH HHS K23HL133454NHLBI NIH HHS U01 AI100119-09S1NIAID NIH HHS K23 AI141686NIAID NIH HHS U01 AI100119
6 · The paper itself

Abstract

backgroundMultisystem inflammatory syndrome in children (MIS-C) is a severe life-threatening manifestation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection that often presents with acute cardiac dysfunction and cardiogenic shock. While recovery from acute illness is excellent, the long-term myocardial impact is unknown.

objectiveTo compare cardiac MRI findings in children 6-9 months after their hospitalization with MIS-C against MRI findings in healthy controls to assess for residual myocardial disease. MATERIALS AND

methodsWe prospectively performed cardiac MRI on 13 children 6-9 months following their hospitalization with MIS-C: eight of these children had a history of left ventricle ejection fraction (LVEF) < 50%, persistent symptoms, or electrocardiogram (ECG) abnormalities and underwent clinical MRI; five of these children without cardiac abnormalities during their hospitalization underwent research MRIs. We compared their native T1 and T2 mapping values with those of 20 normal controls.

resultsCardiac MRI was performed at 13.6 years of age (interquartile range [IQR] 11.9-16.4 years) and 8.2 months (IQR 6.8-9.6 months) following hospitalization. Twelve children displayed normal ejection fraction: left ventricle (LV) 57.2%, IQR 56.1-58.4; right ventricle (RV) 53.1%, IQR 52.0-55.7. One had low-normal LVEF (52%). They had normal extracellular volume (ECV) and normal T2 and native T1 times compared to controls. There was no qualitative evidence of edema. One child had late gadolinium enhancement (LGE) with normal ejection fraction, no edema, and normal T1 and T2 times. When stratifying children who had MIS-C according to history of LVEF <55% on echocardiography, there was no difference in MRI values.

conclusionAlthough many children with MIS-C present acutely with cardiac dysfunction, residual myocardial damage 6-9 months afterward appears minimal. Long-term implications warrant further study.

Indexed as

CardiomyopathiesCOVID-19ChildContrast MediaGadoliniumHospitalizationHumansInfantMagnetic Resonance ImagingMagnetic Resonance Imaging, CineMyocardiumPredictive Value of TestsProspective StudiesSARS-CoV-2Stroke VolumeSystemic Inflammatory Response SyndromeContrast MediaGadoliniumChildrenCoronavirus disease 2019HeartMagnetic resonance imagingModified Look-Locker inversion recoveryMultisystem inflammatory syndrome in childrenSevere acute respiratory syndrome coronavirus 2T1 mappingT2 mapping

Identifiers

PMID36255453
PMCPMC9579624
OpenAlexW4306671067

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.